Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
Expert Opinion on Investigational Drugs|March 14, 2017
Cadazolid for the treatment of Clostridium difficileBradley T Endres, Eugénie Bassères, M Jahangir Alam, et al.Scientific Reports|March 24, 2017
The Role of Angiotensin II in Glomerular Volume Dynamics and Podocyte Calcium HandlingDaria V Ilatovskaya, Oleg Palygin, Vladislav Levchenko, et al.Journal of Visualized Experiments : Jove|July 2, 2015
Two-photon Imaging of Intracellular Ca2+ Handling and Nitric Oxide Production in Endothelial and Smooth Muscle Cells of an Isolated Rat AortaBradley T Endres, Alexander Staruschenko, Marie Schulte, et al.Current Opinion in Gastroenterology|January 31, 2017
Novel antibiotics in development to treat Clostridium difficile infectionEugénie Bassères, Bradley T Endres, Kierra M Dotson, et al.Antimicrobial Agents and Chemotherapy|June 24, 2015
Innate inflammatory response and immunopharmacologic activity of micafungin, caspofungin, and voriconazole against wild-type and FKS mutant Candida glabrata isolatesNicholas D Beyda, Guangling Liao, Bradley T Endres, et al.Antimicrobial Agents and Chemotherapy|March 30, 2016
Evaluating the Effects of Surotomycin Treatment on Clostridium difficile Toxin A and B Production, Immune Response, and Morphological ChangesBradley T Endres, Eugénie Bassères, Mohammed Khaleduzzaman, et al.Expert Opinion on Investigational Drugs|February 16, 2019
Ridinilazole for the treatment of Clostridioides difficile infectionTravis J Carlson, Bradley T Endres, Eugénie Bassères, et al.Nitric Oxide : Biology and Chemistry|November 13, 2017
Nitric oxide production by glomerular podocytesOleg Palygin, Daria V Ilatovskaya, Vladislav Levchenko, et al.The Journal of Antimicrobial Chemotherapy|February 21, 2016
Impact on toxin production and cell morphology in Clostridium difficile by ridinilazole (SMT19969), a novel treatment for C. difficile infectionEugénie Bassères, Bradley T Endres, Mohammed Khaleduzzaman, et al.American Journal of Physiology. Heart and Circulatory Physiology|December 6, 2015
The NRF2 knockout rat: a new animal model to study endothelial dysfunction, oxidant stress, and microvascular rarefactionJessica R C Priestley, Katie E Kautenburg, Marc C Casati, et al.Pageof 4